RXDX
Prometheus Biosciences, Inc.
NASDAQHealthcareBiotechnologyUS
Company Profile
CEO
Mark C. McKenna
IPO Date
2021-03-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Prometheus Biosciences, Inc.
CEO
Mark C. McKenna
IPO Date
2021-03-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 178,098 |
| $200.00 |
| 16 Jun 2023 | McKenna Mark C. | director, officer: Chairman, President and CEO | D-Return | Disposed | 161,105 | $2.90 |
| 16 Jun 2023 | McKenna Mark C. | director, officer: Chairman, President and CEO | D-Return | Disposed | 132,741 | $1.70 |
| 16 Jun 2023 | McKenna Mark C. | director, officer: Chairman, President and CEO | D-Return | Disposed | 20,000 | $3.10 |
| 16 Jun 2023 | McKenna Mark C. | director, officer: Chairman, President and CEO | D-Return | Disposed | 481,725 | $3.70 |
| 16 Jun 2023 | McKenna Mark C. | director, officer: Chairman, President and CEO | D-Return | Disposed | 290,000 | $36.32 |
| 16 Jun 2023 | McKenna Mark C. | director, officer: Chairman, President and CEO | D-Return | Disposed | 246,639 | $29.56 |
| 16 Jun 2023 | McKenna Mark C. | director, officer: Chairman, President and CEO | D-Return | Disposed | 128,930 | $110.20 |
| 16 Jun 2023 | Marshall Keith W | Chief Financial Officer | D-Return | Disposed | 87,973 | $200.00 |